Leflunomide
SIGMA/L5025 - Immunosuppressant
Synonym: 5-
CAS Number: 75706-12-6
Empirical Formula (Hill Notation): C12H9F3N2O2
Molecular Weight: 270.21
MDL Number: MFCD00867593
Linear Formula: C12H9F3N2O2
Product Type: Chemical
| assay | ≥98% (TLC) |
| form | powder |
| InChI | 1S/C12H9F3N2O2/c1-7-10(6- |
| InChI key | VHOGYURTWQBHIL-UHFFFAOYSA |
| mode of action | enzyme | inhibits |
| mp | 166.5 °C |
| Quality Level | 200 ![]() |
| SMILES string | Cc1oncc1C(=O)Nc2ccc(cc2)C |
| solubility | methanol: 19.60-20.40 mg/mL, clear, colorless to faintly yellow |
| storage temp. | 2-8°C |
| Application: | By virtue of its immunosuppressant effects, leflunomide has found use in organ transplantation and treatment of rheumatoid arthritis and other autoimmune diseases. |
| Biochem/physiol Actions: | Immunosuppressive; inhibits T and B cell proliferation. Activity is attributed mainly to its metabolite, a malononitrile derivative, which is believed to inhibit dihydroorotate dehydrogenase (in the de novo pyrimidine synthesis pathway) as well as several protein tyrosine kinases. |
| Packaging: | 25, 100 mg in poly bottle |
| Symbol | GHS06 |
| Signal word | Danger |
| Hazard statements | H301 - H315 - H319 - H335 |
| Precautionary statements | P261 - P264 - P270 - P301 + P310 - P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xn |
| Risk Statements | 22-36/37/38 |
| Safety Statements | 26 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 1 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (TLC) |
| mp | 166.5 °C |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352202 |


